Brief: CytRx reports positive updated Phase 2 Aldoxorubicin clinical trial results in glioblastoma multiforme

LadRx

21/05/2015 14:00

May 21 (Reuters) - CytRx Corp  CYTR.O : 
 * Reports positive updated phase 2 aldoxorubicin clinical trial results in 
   glioblastoma multiforme (brain cancer) 
 * Aldoxorubicin was well tolerated at both dose levels,all adverse events 
   consistent with known doxorubicin toxicities, but not cardiotoxity 
 * Says aldoxorubicin has now shown two complete responses, in addition to tumor 
   shrinkage, prolonged stable disease 
 * Addition of avastin following or combined with aldoxorubicin treatment could 
   prolong survival 
 
* Source text for Eikon  ID:nPn2MJ7V0  
 
* Further company coverage  CYTR.O   
 
((Bengaluru Newsroom; +1 646 223 8780))